Cargando…

Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study

Oral potentially malignant disorders (OPMD) are associated with an increased risk of oral squamous cell carcinoma (OSCC). OSCC has an aggressive profile and is the most prevalent among different head and neck malignancies. Most OSCC patients are diagnosed with advanced stage tumors and have a poor p...

Descripción completa

Detalles Bibliográficos
Autores principales: GHOLAMI, Shakiba, CHAMORRO-PETRONACCI, Cintia, PÉREZ-SAYÁNS, Mario, SUÁREZ PEÑARANDA, José, LONGATTO-FILHO, Adhemar, BALTAZAR, Fátima, AFONSO, Julieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade De Odontologia De Bauru - USP 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185307/
https://www.ncbi.nlm.nih.gov/pubmed/37194791
http://dx.doi.org/10.1590/1678-7757-2022-0461
_version_ 1785042327656464384
author GHOLAMI, Shakiba
CHAMORRO-PETRONACCI, Cintia
PÉREZ-SAYÁNS, Mario
SUÁREZ PEÑARANDA, José
LONGATTO-FILHO, Adhemar
BALTAZAR, Fátima
AFONSO, Julieta
author_facet GHOLAMI, Shakiba
CHAMORRO-PETRONACCI, Cintia
PÉREZ-SAYÁNS, Mario
SUÁREZ PEÑARANDA, José
LONGATTO-FILHO, Adhemar
BALTAZAR, Fátima
AFONSO, Julieta
author_sort GHOLAMI, Shakiba
collection PubMed
description Oral potentially malignant disorders (OPMD) are associated with an increased risk of oral squamous cell carcinoma (OSCC). OSCC has an aggressive profile and is the most prevalent among different head and neck malignancies. Most OSCC patients are diagnosed with advanced stage tumors and have a poor prognosis. Cancer cells are able to reprogram their metabolism, even in the presence of oxygen, enhancing the conversion of glucose to lactate via the glycolytic pathway, a phenomenon mainly regulated by hypoxia-inducible factor (HIF) signaling. Thus, several glycometabolism-related biomarkers are upregulated. OBJECTIVES: This study aimed to evaluate the immunoexpression of the HIF targets GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4, and CAIX in OPMD and OSCC samples, in order to identify potential correlations between biomarkers’ immunoexpression, clinicopathological features, and prognostic parameters. METHODOLOGY: OSCC and OPMD samples from 21 and 34 patients (respectively) were retrospectively collected and stained for the different biomarkers by immunohistochemistry. RESULTS: CAIX and MCT4 expressions were significantly higher in OSCC samples when compared with OPMD samples, while the rest were also expressed by OPMD. GLUT3 and PKM2 alone, and the concomitant expression of more than four glycometabolism-related biomarkers were significantly correlated with the presence of dysplasia in OPMD. When considering OSCC cases, a trend toward increased expression of biomarkers and poor clinicopathological features was observed, and the differences regarding HK2, PFKL, LDHA and MCT4 expression were significant. Moreover, HK2 and CAIX were correlated with low survival rates. GLUT1 and GLUT3 were significantly associated with poor outcome when their expression was observed in the hypoxic region of malignant lesions. CONCLUSION: OPMD and OSCC cells overexpress glycolysis-related proteins, which is associated with aggressive features and poor patient outcome. Further research is needed to deeply understand the glycolic phenotype in the process of oral carcinogenesis.
format Online
Article
Text
id pubmed-10185307
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Faculdade De Odontologia De Bauru - USP
record_format MEDLINE/PubMed
spelling pubmed-101853072023-05-16 Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study GHOLAMI, Shakiba CHAMORRO-PETRONACCI, Cintia PÉREZ-SAYÁNS, Mario SUÁREZ PEÑARANDA, José LONGATTO-FILHO, Adhemar BALTAZAR, Fátima AFONSO, Julieta J Appl Oral Sci Original Article Oral potentially malignant disorders (OPMD) are associated with an increased risk of oral squamous cell carcinoma (OSCC). OSCC has an aggressive profile and is the most prevalent among different head and neck malignancies. Most OSCC patients are diagnosed with advanced stage tumors and have a poor prognosis. Cancer cells are able to reprogram their metabolism, even in the presence of oxygen, enhancing the conversion of glucose to lactate via the glycolytic pathway, a phenomenon mainly regulated by hypoxia-inducible factor (HIF) signaling. Thus, several glycometabolism-related biomarkers are upregulated. OBJECTIVES: This study aimed to evaluate the immunoexpression of the HIF targets GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4, and CAIX in OPMD and OSCC samples, in order to identify potential correlations between biomarkers’ immunoexpression, clinicopathological features, and prognostic parameters. METHODOLOGY: OSCC and OPMD samples from 21 and 34 patients (respectively) were retrospectively collected and stained for the different biomarkers by immunohistochemistry. RESULTS: CAIX and MCT4 expressions were significantly higher in OSCC samples when compared with OPMD samples, while the rest were also expressed by OPMD. GLUT3 and PKM2 alone, and the concomitant expression of more than four glycometabolism-related biomarkers were significantly correlated with the presence of dysplasia in OPMD. When considering OSCC cases, a trend toward increased expression of biomarkers and poor clinicopathological features was observed, and the differences regarding HK2, PFKL, LDHA and MCT4 expression were significant. Moreover, HK2 and CAIX were correlated with low survival rates. GLUT1 and GLUT3 were significantly associated with poor outcome when their expression was observed in the hypoxic region of malignant lesions. CONCLUSION: OPMD and OSCC cells overexpress glycolysis-related proteins, which is associated with aggressive features and poor patient outcome. Further research is needed to deeply understand the glycolic phenotype in the process of oral carcinogenesis. Faculdade De Odontologia De Bauru - USP 2023-05-15 /pmc/articles/PMC10185307/ /pubmed/37194791 http://dx.doi.org/10.1590/1678-7757-2022-0461 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
GHOLAMI, Shakiba
CHAMORRO-PETRONACCI, Cintia
PÉREZ-SAYÁNS, Mario
SUÁREZ PEÑARANDA, José
LONGATTO-FILHO, Adhemar
BALTAZAR, Fátima
AFONSO, Julieta
Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
title Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
title_full Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
title_fullStr Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
title_full_unstemmed Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
title_short Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
title_sort immunoexpression profile of hypoxia-inducible factor (hif) targets in potentially malignant and malignant oral lesions: a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185307/
https://www.ncbi.nlm.nih.gov/pubmed/37194791
http://dx.doi.org/10.1590/1678-7757-2022-0461
work_keys_str_mv AT gholamishakiba immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy
AT chamorropetronaccicintia immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy
AT perezsayansmario immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy
AT suarezpenarandajose immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy
AT longattofilhoadhemar immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy
AT baltazarfatima immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy
AT afonsojulieta immunoexpressionprofileofhypoxiainduciblefactorhiftargetsinpotentiallymalignantandmalignantorallesionsapilotstudy